Evidence map›Paper›PMID 28887153›Full record

ReviewThe international journal of biochemistry & cell biology2018

The Eya phosphatase: Its unique role in cancer.

Hengbo Zhou, Lingdi Zhang, Rebecca L Vartuli, Heide L Ford, Rui Zhao

Erratum issuedAbstract readReview
In one paragraph

Review in The international journal of biochemistry & cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.Biochimica et biophysica acta. Reviews on cancer · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Genetic research progress in branchioZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hengbo ZhouDepartment of Pharmacology, University of Colorado Denver Anschutz Medical Campus, United States; Cancer Biology Program, University of Colorado Denver Anschutz Medical Campus, United States Cancer Biology Program, United States.
Lingdi ZhangDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver Anschutz Medical Campus, United States.
Rebecca L VartuliDepartment of Pharmacology, University of Colorado Denver Anschutz Medical Campus, United States; Molecular Biology Program, University of Colorado Denver Anschutz Medical Campus, United States Molecular Biology Program, United States.
Heide L FordDepartment of Pharmacology, University of Colorado Denver Anschutz Medical Campus, United States; Cancer Biology Program, University of Colorado Denver Anschutz Medical Campus, United States Cancer Biology Program, United States.
Rui ZhaoDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver Anschutz Medical Campus, United States. Electronic address: rui.zhao@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Cancer Center · USUniversity of Colorado Denver · US

Funding

Role of Eya3 in regulating the immune microenvironment to promote breast tumor progressionR01CA221282 · NCI · UNIVERSITY OF COLORADO DENVER · PI FORD, HEIDE L., ZHAO, RUI · 2017 to 2021
$3.2M
The anti-tumorigenic and anti-metastatic potential of Eya phosphatase inhibitorsR41CA180347 · NCI · SIXONE SOLUTIONS, LLC · PI FORD, HEIDE L., ZHAO, RUI · 2013 to 2013
$293k
Identify inhibitors of the Six1/Eya interaction using high throughput screeningR03DA033174 · NIDA · UNIVERSITY OF COLORADO DENVER · PI FORD, HEIDE L., ZHAO, RUI · 2011 to 2012
$75k
Identify inhibitors of the Eya phosphatase activity using high throughput screeniR03DA030559 · NIDA · UNIVERSITY OF COLORADO DENVER · PI FORD, HEIDE L., ZHAO, RUI · 2010 to 2011
$74k
NCI NIH HHS R01 CA221282NCI NIH HHS R41 CA180347NIDA NIH HHS R03 DA030559NIDA NIH HHS R03 DA033174
6 · The paper itself

Abstract

The Eya proteins were originally identified as essential transcriptional co-activators of the Six family of homeoproteins. Subsequently, the highly conserved C-terminal domains of the Eya proteins were discovered to act as a Mg

Indexed as

AnimalsDNA-Binding ProteinsDNA DamageDNA RepairHumansNeoplasm ProteinsNeoplasmsProtein Tyrosine PhosphatasesDNA-Binding ProteinsNeoplasm ProteinsProtein Tyrosine PhosphatasesCancerEyaInhibitorPhosphataseSer/Thr phosphataseTyr phosphatase

Identifiers

PMID28887153
PMCPMC5808901
OpenAlexW2753865572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.